Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
After finishing at $57.6 in the prior trading day, Procept BioRobotics Corp (NASDAQ: PRCT) closed at $56.57, down -1.79%. In other words, the price has decreased by -$1.79 from its previous closing price. On the day, 0.55 million shares were traded. PRCT stock price reached its highest trading level at $58.62 during the session, while it also had its lowest trading level at $56.25.
Ratios:
Our goal is to gain a better understanding of PRCT by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.74 and its Current Ratio is at 8.94. In the meantime, Its Debt-to-Equity ratio is 0.21 whereas as Long-Term Debt/Eq ratio is at 0.20.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Morgan Stanley on December 02, 2024, initiated with a Overweight rating and assigned the stock a target price of $105.
On November 14, 2024, Jefferies started tracking the stock assigning a Hold rating and target price of $95.
On August 11, 2023, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $42.Piper Sandler initiated its Overweight rating on August 11, 2023, with a $42 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 10 ’25 when Desai Antal Rohit sold 25,000 shares for $63.91 per share. The transaction valued at 1,597,711 led to the insider holds 64,363 shares of the business.
Desai Antal Rohit sold 25,000 shares of PRCT for $1,584,525 on Jun 11 ’25. The Director now owns 39,363 shares after completing the transaction at $63.38 per share. On Jun 12 ’25, another insider, Desai Antal Rohit, who serves as the Director of the company, sold 25,000 shares for $61.49 each. As a result, the insider received 1,537,256 and left with 14,363 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PRCT now has a Market Capitalization of 3129944576 and an Enterprise Value of 2952537344. For the stock, the TTM Price-to-Sale (P/S) ratio is 12.56 while its Price-to-Book (P/B) ratio in mrq is 8.04. Its current Enterprise Value per Revenue stands at 11.852 whereas that against EBITDA is -32.489.
Stock Price History:
The Beta on a monthly basis for PRCT is 1.07, which has changed by -0.110814214 over the last 52 weeks, in comparison to a change of 0.11937654 over the same period for the S&P500. Over the past 52 weeks, PRCT has reached a high of $103.81, while it has fallen to a 52-week low of $47.04. The 50-Day Moving Average of the stock is -1.50%, while the 200-Day Moving Average is calculated to be -20.20%.
Shares Statistics:
The stock has traded on average 972.73K shares per day over the past 3-months and 677130 shares per day over the last 10 days, according to various share statistics. A total of 55.28M shares are outstanding, with a floating share count of 52.60M. Insiders hold about 4.93% of the company’s shares, while institutions hold 91.64% stake in the company. Shares short for PRCT as of 1749772800 were 6716837 with a Short Ratio of 6.91, compared to 1747267200 on 5896227. Therefore, it implies a Short% of Shares Outstanding of 6716837 and a Short% of Float of 14.399999999999999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
